1. Immunogenicity of Non-Mutated Ovarian Cancer-Specific Antigens.
- Author
-
Hesnard, Leslie, Thériault, Catherine, Cahuzac, Maxime, Durette, Chantal, Vincent, Krystel, Hardy, Marie-Pierre, Lanoix, Joël, Lavallée, Gabriel Ouellet, Humeau, Juliette, Thibault, Pierre, and Perreault, Claude
- Subjects
IMMUNE response ,ANTIGENS ,OVARIAN epithelial cancer ,DENDRITIC cells ,PEPTIDOMIMETICS - Abstract
Epithelial ovarian cancer (EOC) has not significantly benefited from advances in immunotherapy, mainly because of the lack of well-defined actionable antigen targets. Using proteogenomic analyses of primary EOC tumors, we previously identified 91 aberrantly expressed tumor-specific antigens (TSAs) originating from unmutated genomic sequences. Most of these TSAs derive from non-exonic regions, and their expression results from cancer-specific epigenetic changes. The present study aimed to evaluate the immunogenicity of 48 TSAs selected according to two criteria: presentation by highly prevalent HLA allotypes and expression in a significant fraction of EOC tumors. Using targeted mass spectrometry analyses, we found that pulsing with synthetic TSA peptides leads to a high-level presentation on dendritic cells. TSA abundance correlated with the predicted binding affinity to the HLA allotype. We stimulated naïve CD8 T cells from healthy blood donors with TSA-pulsed dendritic cells and assessed their expansion with two assays: MHC-peptide tetramer staining and TCR Vβ CDR3 sequencing. We report that these TSAs can expand sizeable populations of CD8 T cells and, therefore, represent attractive targets for EOC immunotherapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF